Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases
September 28, 2017 - Toronto ON CAXtalks Life Science Webinars
ecoman@xtalks.com
Phone:416 977 6555 ex 371
David O'Connell, Director of Scientific Affairs at PCI Pharma Services, will share how highly potent APIs can be developed and manufactured into suitable drug products that meet the quality target profiles. Attendees will learn about the complexities for each of the clinical phases, from drug in capsule to complex formulations, and how to guide your highly potent API, to commercial supplies for solid oral products, non-sterile oral liquid and semi-solids.
This website uses cookies to ensure you get the best experience on our website. Learn more